DSIJ Mindshare

Gravita India: Lead production commences at Tanzania plant

Apurva Joshi 0 2995 Article rating: 5.0

Gravita India Limited has informed the bourses that its step-down subsidiary Gravita Tanzania Limited which is situated in Tanzania, East Africa has started commercial production of lead from its new plant having an annual capacity of 3,000 MTPA. It is the first export-oriented recycling plant in Tanzania.

Alembic Pharma receives approval for Teriflunomide tablets

Advait Dharmadhikari 0 1386 Article rating: 5.0

Alembic Pharma announced that the company has received approval from the USFDA for its Abbreviated New Drug Application (ANDA) Teriflunomide Tablets, 7 mg and 14 mg. The approved ANDA is therapeutically equivalent to the reference listed drug(RLD), Aubagio Tablets, 7 mg and 14 mg, of Sanofi- Aventis. Teriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis.

RSS
First50995100510151025104510651075108Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR